Scleroderma Foundation eLetter

Archive

Management of Interstitial (ILD) and Fibrotic Lung Disease

How is ILD diagnosed?
When the diagnosis of ILD is suspected, your doctor considers the following:

Your Medical History:

This includes a review of any symptoms suggestive of connective tissue diseases, a listing of all current and former medications, and a review of any environmental and occupational exposures to dusts, gases, chemicals, pets (in particular birds), air conditioners, and humidifiers.


Friday, May 25, 2007– Issue #195	eLetter Archive

Staying on Schedule

The Scleroderma Foundation is proud to announce the schedule of workshops and presenters for its 2007 National Patient Education Conference in Philadelphia July 20–22.

In the Spotlight – National Conference Workshops and Presenters

"Qualifying for Disability Benefits: Everything You Need to Know for a Successful Claim"

~ AND ~

"Managing Localized Scleroderma"

This series will appear weekly until the conference in July.

Imatinib Could Boost Systemic Scleroderma Tx

DESTIN, FLA. — Imatinib mesylate was shown in a recent small study to have potent antifibrotic effects, suggesting it may be of benefit for the treatment of fibrotic diseases such as systemic scleroderma, Dr. Steffen Gay reported at the annual Rheumatology on the Beach.

Scleroderma with Calcinosis

by Stephanie Eschenbach, MD; Thomas L. Pope, Jr., MD, FACR

Requires free login and password to Medscape.

Arthritis: Chemotherapy Drugs to Treat Arthritis

In cancer treatment, chemotherapy refers to particular drugs used to kill or slow the reproduction of rapidly multiplying cells. In rheumatology, chemotherapy is designed to decrease the abnormal behavior of cells, rather than kill cells. The doses of medication used for rheumatic or autoimmune conditions are lower than the doses used for cancer treatment.

New Criteria Debut for Classifying Juvenile Systemic Sclerosis

Evidence of proximal cutaneous sclerosis and at least 2 of 20 predefined minor criteria are required for a diagnosis of juvenile systemic sclerosis, according to recently released provisional classification criteria.

Watch David Gilliland Race!

Watch David Gilliland race the No. 25 Ford Fusion tomorrow night at 7:30 p.m. on ESPN 2 in the NASCAR Busch Series Carquest Auto Parts 300 in Concord, North Carolina. The Foundation is an associate sponsor of the No. 25 vehicle.

Upcoming Events

	June 1 (Fri.): Third Annual Drive for a Cure Golf Tournament (Ada, Mich.)
	June 2 (Sat.): Stepping Out to Cure Scleroderma Walk (Corpus Christi, Texas)
	June 2 (Sat.): Stepping Out to Cure Scleroderma Walk (Chaska, Minn. – AND – Park Point, Duluth, Minn.)
	June 2 (Sat.): 10th Annual Ellen Ehrhart Medical Symposium (Pompano Beach, Fla.)
	June 3 (Sun.): Stepping Out to Cure Scleroderma Walk (Belmar, N.J.)
	July 20–22 (Fri.–Sun.): Scleroderma Foundation's National Conference (Philadelphia, Penn.)
SF June Calendar

Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923
Phone 978-463-5843 · 800-722-HOPE (4673)

If you cannot view the eLetter, or the links do not work, you can read it on the Web at www.scleroderma.org/e-letters/eLetter_195.htm. If someone has forwarded this eLetter to you, and you wish to subscribe to this FREE weekly publication, go to www.scleroderma.org/e_letter_signup.shtm.